Skip to main content
. 2021 Apr 22;11:8722. doi: 10.1038/s41598-021-87929-x

Table 1.

Characteristics of T1 stage colorectal cancer patients with or without distant metastasis.

Overall Distant metastasis P value
N = 21,321 No (M0)
N = 20,942
Yes (M1)
N = 379
Age (years)
< 60 7831 (36.7) 7666 (36.6) 165 (43.5) 0.0055
≥ 60 13,490 (63.3) 13,276 (63.4) 214 (56.5)
Gender
Male 11,508 (54.0) 11,298 (54.0) 210 (55.4) 0.5720
Female 9813 (46.0) 9644 (46.0) 169 (44.6)
Marital status
Married 12,054 (56.5) 11,867 (56.7) 187 (49.3) < 0.0001
Single* 7364 (34.5) 7190 (34.3) 174 (45.9)
Unknown 1903 (8.9) 1885 (9.0) 18 (4.8)
Race
White 16,350 (76.7) 16,069 (76.7) 281 (74.1) 0.0013
Black 2417 (11.3) 2355 (11.3) 62 (16.4)
Other 2190 (10.3) 2154 (10.3) 36 (9.5)
Unknown 364 (1.7) 364(1.7) 0 (0)
Tumor deposit
Negative 17,079 (80.1) 16,890 (80.7) 189 (49.9) < 0.0001
Positive 176 (0.8) 157 (0.8) 19 (5.0)
Unknown 4066 (19.1) 3895 (18.6) 171 (45.1)
Harvested lymph nodes
0–12 11,613 (54.5) 11,346 (54.2) 267 (70.5) < 0.0001
> 12 9547 (44.8) 9440 (45.1) 107 (28.2)
Unknown 161 (0.8) 156 (0.7) 5 (1.3)
Positive lymph nodes
No 12,798 (60.0) 12,712 (60.7) 86 (22.7) < 0.0001
Yes 1691 (7.9) 1620 (7.7) 71 (18.7)
Unknown 6832 (32.0) 6610 (31.6) 222 (58.6)
CEA status
Negative 7080 (33.2) 7015 (33.5) 65 (17.2) < 0.0001
Positive 1376 (6.5) 1184 (5.7) 192 (50.7)
Unknown 12,865 (60.3) 12,743 (60.9) 122 (32.2)
Liver metastasis
No 21,056 (98.8) 20,942 (100) 114 (30.1)
Yes 265 (1.24) 0 (0) 265 (69.9)
Lung metastasis
No 21,243 (99.6) 20,942 (100) 301 (79.4)
Yes 78 (0.4) 0 78 (20.6)
Insurance
No 374 (1.8) 361 (1.7) 13 (3.4) 0.0271
Yes 20,046 (94.0) 19,692 (94.0) 354 (93.4)
Unknown 901 (4.2) 889 (4.3) 12 (3.2)
Localization
Colon 16,620 (78.0) 16,328 (78.0) 292 (77.0) 0.6676
Rectum 4701 (22.0) 4614 (22.0) 87 (33.0)
Histology
Adenocarcinoma 20,823 (97.7) 20,483 (97.8) 340 (89.7) < 0.0001
Mucinous 450 (2.1) 418 (2.0) 32 (7.1)
Signet-ring cell 48 (0.2) 41 (0.2) 7 (1.9)
Grade < 0.0001
Well differentiated 3895 (18.3) 3857 (18.4) 38 (10.0)
Moderately differentiated 13,214 (62.0) 13,015 (62.2) 199 (52.5)
Poorly differentiated 1182 (5.5) 1134 (5.4) 48 (12.7)
Undifferentiated 173 (0.8) 169 (0.8) 4 (1.1)
Unknown 2857 (13.4) 2767 (13.2) 90 (23.8)
Tumor size
≤ 5 cm 13,288 (62.3) 13,140 (62.7) 148 (39.1) < 0.0001
> 5 cm 1122 (5.3) 1057 (5.1) 65 (17.2)
Unknown 6911 (32.4) 6745 (32.2) 166 (43.8)
N stage
N0 19,094 (90.0) 18,861 (90.1) 233 (61.5) < 0.0001
N1 1617 (7.6) 1531 (7.3) 86 (22.7)
N2 190 (0.9) 157 (0.8) 33 (8.7)
Unknown 420 (2.0) 393 (1.9) 27 (7.1)
Perineural invasion
No 16,865 (79.1) 16,665 (79.6) 200 (52.8) < 0.0001
Yes 185 (0.9) 173 (0.8) 12 (3.2)
Unknown 4271 (20.0) 4104 (19.6) 167 (44.1)
Radiotherapy
No 20,875 (97.9) 20,521 (98.0) 354 (93.4) < 0.0001
Yes 446 (2.1) 421 (2.0) 25 (6.6)
Chemotherapy
No 19,527 (91.6) 19,416 (92.7) 111 (29.3) < 0.0001
Yes 1794 (8.4) 1526 (7.3) 268 (70.7)
Metastasectomy
No 21,207 (99.5) 20,884 (99.7) 323 (85.2) < 0.0001
Yes 114 (0.5) 58 (0.3) 56 (14.8)
Survival
No 981 (4.6) 762 (3.6) 219 (57.8) < 0.0001
Yes 20,340 (95.4) 20,180 (96.4) 160 (42.2)
Overall survival
No 18,400 (86.3) 18,267 (87.2) 133 (35.1) < 0.0001
Yes 2921 (13.7) 2675 (12.8) 246 (64.9)
Median survival time (months) 40 41.0 19.0
5-year survival rate (%) 82.8 95.9 33.2 < 0.0001

*Single includes divorces/separated/widowed/unmarried.